The Patent Finder

Arthrodynamic Holdings, LLC

Also on record
Records under this name other than the patents Arthrodynamic Holdings, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 10 of 10 · Back to Arthrodynamic Holdings, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,455,458Composition and method for treating connective tissue damage
Term ended
Term ended Oct 14, 2025 · USPTO record
Term endedTerm ended Oct 14, 2025USPTO record
US 9,186,375Glycosaminoglycan compositions in combination with stem cells
Term ended
Term ended Jul 12, 2024 · USPTO record
Term endedTerm ended Jul 12, 2024USPTO record
US 7,485,629Composition and method for treatment of joint damage
Term ended
Term ended Jun 1, 2024 · USPTO record
Term endedTerm ended Jun 1, 2024USPTO record
US 6,979,679Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage
Term ended
Term ended May 11, 2024 · USPTO record
Term endedTerm ended May 11, 2024USPTO record
US 7,504,387Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
Term ended
Term ended Apr 11, 2024 · USPTO record
Term endedTerm ended Apr 11, 2024USPTO record
US 8,580,766Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
Term ended
Ended no later than Oct 16, 2023 · USPTO record
Term endedEnded no later than Oct 16, 2023USPTO record
US 8,871,742Composition and method for treating connective tissue damage
Term ended
Ended no later than Oct 16, 2023 · USPTO record
Term endedEnded no later than Oct 16, 2023USPTO record
US 9,937,209Glycosaminoglycan compositions in combination with stem cells
Term ended
Term ended Oct 16, 2023 · USPTO record
Term endedTerm ended Oct 16, 2023USPTO record
US 7,803,787Composition and method for treating connective tissue damage by transmucosal administration
Lapsed on the fee record
Ended Sep 28, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 28, 2022USPTO record
US 9,381,211Composition and method for treating connective tissue damage
Lapsed on the fee record
Ended Jul 5, 2020 · USPTO record
Lapsed on the fee recordEnded Jul 5, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited